Skip to main content

Valeant has officially given up its $1 billion bet on the ‘female Viagra’

Despite predictions of a huge market, Addyi’s sales have faltered, even after a bid earlier this year to invigorate them.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.